Trials / Completed
CompletedNCT00516776
The Innate Immune System and Inflammatory Bowel Disease
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 400 (actual)
- Sponsor
- Norwegian University of Science and Technology · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The study includes individuals with ulcerative colitis, Crohn's disease and healthy controls. The purpose of this study is to examine the innate immune system (IIS) by exposing peripheral blood monocytes to various ligands relevant for stimulation of the IIS and study the immune response. Colonic mucosal samples are examined to find gene expression patterns which may distinguish the two forms of disease from each other and from healthy controls. The hypothesis is that the innate immune system has responses unique for the disease states, and that the diseases may be differentiated by examination of gene expression patterns in mucosal biopsies.
Conditions
Timeline
- Start date
- 2007-06-01
- Primary completion
- 2017-12-01
- Completion
- 2017-12-01
- First posted
- 2007-08-15
- Last updated
- 2018-02-14
Locations
1 site across 1 country: Norway
Source: ClinicalTrials.gov record NCT00516776. Inclusion in this directory is not an endorsement.